Graft versus host disease: Clinical evaluation, diagnosis and management

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 5, 2013, Pages 1257-1266

  Espana, Edgar M ^a   Shah, Sejal ^a   Santhiago, Marcony R ^b   Singh, Arun D ^b,c  

^a Department of Ophthalmology ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Dry eye; GVHD; Keratinization; Ocular surface inflammation; Stem cells transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; EYE DROPS; LUBRICATING AGENT; TACROLIMUS; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

CLINICAL EVALUATION; CONJUNCTIVA; CONJUNCTIVITIS; CORNEA; DONOR; DRY EYE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATORY DISEASE; KERATOPATHY; LACRIMAL GLAND; LONG TERM CARE; MEIBOMIAN GLAND; OPHTHALMOLOGIST; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; REVIEW; SCLERAL CONTACT LENS; TISSUE INJURY; BONE MARROW TRANSPLANTATION; CONJUNCTIVA DISEASE; CONTACT LENS; CORNEA DISEASE; EYE DISEASE; EYELID DISEASE; LACRIMAL GLAND DISEASE; PHYSIOLOGY; SERUM; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; CONJUNCTIVAL DISEASES; CONTACT LENSES; CORNEAL DISEASES; DRY EYE SYNDROMES; EYE DISEASES; EYELID DISEASES; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LACRIMAL APPARATUS DISEASES; LUBRICANTS; SERUM; STEM CELL TRANSPLANTATION;

EID: 84884194574     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-013-2301-z     Document Type: Review

References (51)

1. Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813-1826
2. Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550-1561
3. de la Morena MT, Gatti RA (2010) A history of bone marrow transplantation. Immunol Allergy Clin North Am 30:1-15
4. Choi SW, Levine JE, Ferrara JL (2010) Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 30:75-101
5. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/ progenitor cells. Proc Natl Acad Sci U S A 86:3828-3832 (Pubitemid 19141838)
6. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ (2002) Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8:257-260 (Pubitemid 34619076)
7. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618 (Pubitemid 34925136)
8. Uchino M, Ogawa Y, Uchino Y, Mori T, Okamoto S, Tsubota K (2012) Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 96:34-37
9. Platzbecker U, Ehninger G, Bornhauser M (2004) Allogeneic transplantation of CD34+ selected hematopoietic cells - clinical problems and current challenges. Leuk Lymphoma 45:447-453 (Pubitemid 38196026)
10. Wagner JE, Thompson JS, Carter SL, Kernan NA (2005) Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase 2-3 trial. Lancet 366:733-741 (Pubitemid 41207235)
11. Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS (2011) Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood 117:3268-3276
12. Socie G, Blazar BR (2009) Acute graft-versus-host disease: from the bench to the bedside. Blood 114:4327-4336
13. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME (2005) Biol Blood Marrow Transplant 11:945-956
14. Ram R, Gafter-Gvili A, Yeshurun M, Paul M, Raanani P, Shpilberg O (2009) Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant 43:643-653
15. Sale GE (1996) Does graft-versus-host disease attack epithelial stem cells? Mol Med Today 2:114-119 (Pubitemid 126407729)
16. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, Ono M, Yang HY, Mashima Y, Oguchi Y, Ikeda Y, Tsubota K (1999) Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 83:1125-1130 (Pubitemid 29469114)
17. Kim SK (2006) Update on ocular graft versus host disease. Curr Opin Ophthalmol 17:344-348 (Pubitemid 44215042)
18. Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A (2010) Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 29:758-763
19. Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H, Nepp J, Lawitschka A, Heiligenhaus A, Seitz B, Messmer EM, Meyer-ter-Vehn T, Basara N, Greinix H, Datiles MB, Lee SJ, Pavletic SZ, Wolff D (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea 31:299-310
20. West RH, Szer J, Pedersen JS (1991) Ocular surface and lacrimal disturbances in chronic graft-versus-host disease: the role of conjunctival biopsy. Aust N Z J Ophthalmol 19:187-191
21. Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19-S27 (Pubitemid 37169601)
22. Riemens A, Te BL, Imhof S, Kuball J, Rothova A (2010) Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol 21:485-494
23. Ban Y, Ogawa Y, Ibrahim OM, Tatematsu Y, Kamoi M, Uchino M, Yaguchi S, Dogru M, Tsubota K (2011) Morphologic evaluation ofmeibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533-2543
24. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624-1629
25. Koch KR, Joussen AM, Huber KK (2011) Ocular involvement in chronic graft-versus-host disease: therapeutic approaches to complicated courses. Cornea 30:107-113
26. Savini G, Prabhawasat P, Kojima T, Espana E (2008) The challenge of dry eye diagnosis. Clin Ophthalmol 2:31-55
27. Wang Y, Ogawa Y, Dogru M, Tatematsu Y, Uchino M, Kamoi M, Okada N, Okamoto S, Tsubota K (2010) Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant 45:1077-1083
28. Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH, Pidala J, Khera N, Vogelsang GB, Weisdorf D, Martin PJ, Pavletic SZ, Lee SJ, Chronic GVHD Consortium (2012) Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 119:487-493
29. Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE,Witherspoon RP, Storb R, Appelbaum FR, Martin PJ (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100:48-51 (Pubitemid 35177427)
30. Robinson MR, Lee SS, Rubin BI (2004) Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graftversus- host disease. Bone Marrow Transplant 33:1031-1035 (Pubitemid 38744790)
31. Stevenson D, Tauber J, Reis BL (2000) Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderateto- severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 107:967-974
32. Donnenfeld E, Pflugfelder SC (2009) Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol 54:321-338
33. Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107:631-639 (Pubitemid 30191329)
34. Rao SN, Rao RD (2006) Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea 25:674-678 (Pubitemid 44671855)
35. Lelli GJ Jr, Musch DC, Gupta A (2006) Ophthalmic cyclosporine use in ocular GVHD. Cornea 25:635-638 (Pubitemid 44671848)
36. Malta JB, Soong HK, Shtein RM, Musch DC, Rhoades W, Sugar A, Mian SI (2010) Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea 29:1392-1396
37. Simpson D (2000) Drug therapy for acute graft-versus-host disease prophylaxis. J Hematother Stem Cell Res 9:317-325 (Pubitemid 30436460)
38. Ogawa Y, Okamoto S, Kuwana M, Tsubota K (2001) Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea 20:430-434 (Pubitemid 32381828)
39. Tam PM, Young AL, Cheng LL, Lam PT (2010) Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD. Bone Marrow Transplant 45:957-958
40. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459-461 (Pubitemid 14134788)
41. Tsubota K, Goto E, Fujita H (1999) Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 83:390-395 (Pubitemid 29161176)
42. Ogawa Y, Okamoto S, Mori T, Tsubota K (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31:579-583 (Pubitemid 36546837)
43. Pflugfelder SC (2011) Tear dysfunction and the cornea: 68 Edward Jackson Memorial Lecture. Am J Ophthalmol 152:900-909
44. Takahide K, Parker PM,WuM, HwangWY, Carpenter PA,Moravec C, Stehr B, Martin PJ, Rosenthal P, Forman SJ, Flowers ME (2007) Use of fluid-ventilated, gas-permeable scleral lens formanagement of severe keratoconjunctivitis sicca secondary to chronic graft-versushost disease. Biol Blood Marrow Transplant 13:1016-1021 (Pubitemid 47215558)
45. Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versushost disease. Cornea 26:1195-1199 (Pubitemid 350190910)
46. Schornack MM, Baratz KH, Patel SV, Maguire LJ (2008) Jupiter scleral lenses in the management of chronic graft versus host disease. Eye Contact Lens 34:302-305
47. Rowlings PA, Agahan AL, Perez-Simon JA, López A, Caballero D, Hernández E, Barrientos-Gutierrez T, Calonge M (2011) IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97:855-864
48. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295-304
49. Cahn JY,Klein JP, Lee SJ,Milpied N, BlaiseD, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socie G (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 106:1495-1500
50. Sales CS, Johnston LJ, Ta CN (2011) Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination. Cornea 30:143-149
51. Parra-Colin P, Agahan AL, Perez-Simon JA, Lopez A, Caballero D, Hernandez E, Barrientos-Gutierrez T, Calonge M (2011) Dry eye disease in chronic graft-versus-host disease: results from a Spanish retrospective cohort study. Transplant Proc 43:1934-1938